Brooks Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE650L01011
  • NSEID: BROOKS
  • BSEID: 533543
INR
67.29
-0.12 (-0.18%)
BSENSE

Nov 20

BSE+NSE Vol: 70.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 539063,
    "name": "Brooks Lab.",
    "stock_name": "Brooks Lab.",
    "full_name": "Brooks Laboratories Ltd",
    "name_url": "stocks-analysis/brooks-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "67.29",
    "chg": -0.12,
    "chgp": "-0.18%",
    "dir": -1,
    "prev_price": "67.41",
    "mcapval": "199.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533543,
    "symbol": "BROOKS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE650L01011",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "70.11 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/brooks-lab-539063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Brooks Laboratories Downgraded to Strong Sell Amidst Expensive Valuation and Weak Financials",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/brooks-laboratories-downgraded-to-strong-sell-amidst-expensive-valuation-and-weak-financials-4263196",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BrooksLaborator_mojoScore_4263196.png",
        "date": "2026-11-16 08:11:04",
        "description": "Brooks Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating by MarketsMojo as of 13 Nov 2026, reflecting a deteriorating outlook driven primarily by an expensive valuation, stagnant financial trends, weak quality metrics, and unfavourable technical indicators. The pharmaceutical company’s micro-cap status and recent quarterly results have further compounded investor concerns, signalling caution for stakeholders."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4241947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BrooksLaborator_mojoScore_4241947.png",
        "date": "2026-10-28 10:10:44",
        "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 August 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 28 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4228274",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BrooksLaborator_mojoScore_4228274.png",
        "date": "2026-10-17 10:10:44",
        "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 August 2026, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 17 October 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/brooks-laboratories-ltd-surges-to-upper-circuit-on-robust-buying-pressure-4218946",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BrooksLaborator_stocks_hitting_upper_circuit_4218946.png",
        "date": "2026-10-08 11:00:08",
        "description": "At Rs 70.53, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 19.99% on 08 Oct 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 9.99% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/brooks-laboratories-ltd-surges-to-upper-circuit-on-strong-buying-pressure-4216317",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BrooksLaborator_stocks_hitting_upper_circuit_4216317.png",
        "date": "2026-10-06 11:00:09",
        "description": "At Rs 59.66, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 9.99% on 6 Oct 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4216131",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BrooksLaborator_mojoScore_4216131.png",
        "date": "2026-10-06 10:10:36",
        "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4204825",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BrooksLaborator_mojoScore_4204825.png",
        "date": "2026-09-25 10:10:42",
        "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4192368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BrooksLaborator_mojoScore_4192368.png",
        "date": "2026-09-14 10:10:46",
        "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4179344",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BrooksLaborator_mojoScore_4179344.png",
        "date": "2026-09-02 10:11:11",
        "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 September 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 85,
    "sid": "539063",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/brooks-laboratories-539063"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "12-Nov-2026",
      "details": "Intimation of upgrade in Credit Rating",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Nov-2026",
      "details": "Brooks Laboratories Limited has informed the exchange about copy of Newspaper Publication.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended September 30 2026",
      "datetime": "07-Nov-2026",
      "details": "Financial Results for the quarter and half year ended September 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Brooks Laboratories Ltd has announced <strong>1:16</strong> rights issue, ex-date: 28 Jul 23",
          "dt": "2023-07-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Credit Rating

12-Nov-2026 | Source : BSE

Intimation of upgrade in Credit Rating

Announcement under Regulation 30 (LODR)-Newspaper Publication

09-Nov-2026 | Source : BSE

Brooks Laboratories Limited has informed the exchange about copy of Newspaper Publication.

Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended September 30 2026

07-Nov-2026 | Source : BSE

Financial Results for the quarter and half year ended September 30 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Brooks Laboratories Ltd has announced 1:16 rights issue, ex-date: 28 Jul 23